The HIP Trial

HIP stands for: Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn

The HIP Trial is an EU FP7 funded project that will be the largest multicentered European study in Extremely Low Gestational Age Newborns (ELGANs).

Please click here for a summary, for background, for objectives and for impact of the HIP Trial research project.

Newborn in clinic

The aim of the HIP Trial is to develop an effective treatment of hypotension in the extremely low gestational age newbon.

Hypotension cannot only lead to mortality of preterm infants but also to brain injury and impaired neurosensory development. Preterm brain injury has far reaching implications and makes it necessary to perform an appropriate trial to determine whether the infusion of inotropic agents leads to improved outcome.

On the following pages you will find more information about the project, the group of partners involved, our dissemination activities as well as a contact form to get in touch with us.